NCT02319161View on ClinicalTrials.gov

Comparison of Calcium Channel Blockers and Beta Blockers on Tourniquet-induced Hypertension During Intravenous Regional Anesthesia

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions
Hypertension
Interventions
DRUG

Calcium channel blocker and beta blocker

The patients in which systolic blood pressure increased to 150 mmHg and above following tourniquet inflation and in which a bolus dose of calcium channel blocker 10 mg (Diltizem, Mustafa Nevzat İlaç Sanayi Aş) (Group I) or beta blocker 0.5mg/kg (Brevibloc, Eczacıbaşı İlaç Sanayi Aş) (Group II) were administered intravenously constituted the study groups.

All Listed Sponsors
lead

Ankara University

OTHER

NCT02319161 - Comparison of Calcium Channel Blockers and Beta Blockers on Tourniquet-induced Hypertension During Intravenous Regional Anesthesia | Biotech Hunter | Biotech Hunter